A transformative technology for rare mutation detection, biomarker discovery and companion diagnostics
Fast and Cost-Effective Screening of Gene Rearrangement in Cancer Patients
Detection of most gene rearrangements requires large-scale screening of patients during trials. A better alternative to Next Generation Sequencing, PanelChip® is cost-effective, customizable and simple to use. Fast turnaround time, flexible sample throughput and the capability to analyze poor quality/low concentration samples make clinical trials much more efficient.
Working with various pharmaceutical companies, Quark Biosciences has customized PanelChip® to detect all fusion transcripts to a single gene, such as ROS1 or NTRK. Among the latest examples is a MET panel capable of detecting all MET rearrangement and amplification.